Sheila Singh

25PUBLICATIONS
133CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 22, 2026
Integrated genetic screening identifies FEN1 as a selective vulnerability and temozolomide resistance mediator in glioblastoma stem cells.

|Jul 01, 2026
Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.

|Jun 17, 2026
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.

|May 13, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

|Apr 24, 2026
Targeting SRC enhances differentiation and promotes multifaceted cell death mechanisms in recurrent group 3 medulloblastoma.

|Apr 24, 2026
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.

Pageof 5

Frequent Collaborators

8 joint publications

Jason Moffat

6 joint publications

Kevin R Brown

5 joint publications

Kui Zhai

5 joint publications

Daniel Mobilio